Skip to content

M.D.D. PHARMA: what changed

BE 0437.759.119NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2025 and 2026

Net result for the year
€370,209
2025 · €823,861-€453,652
Equity
€565,871
2025 · €195,662+€370,209
Cash
€19,800
2025 · €14,919+€4,881
Balance sheet total
€12.2m
2025 · €11.3m+€938,537

Largest movements

2025 to 2026
Assets
  • Tangible fixed assets +€766,662

    up €766,662 (+24.2%), from €3.2m to €3.9m

    of which Land and buildings: +€876,114

  • Receivables within one year +€377,215

    up €377,215 (+8.2%), from €4.6m to €5.0m

    of which Trade receivables: +€344,901

  • Stocks and contracts -€141,148

    down €141,148 (-5.5%), from €2.6m to €2.4m

Equity and liabilities
  • Trade debts +€2.0m

    up €2.0m (+65.0%), from €3.0m to €5.0m

  • Other debts -€1.1m

    no longer reported in 2026; in 2025 it stood at €1.1m

  • Profit (loss) carried forward +€370,209

    up €370,209 (+1,322%), from €28,012 to €398,221

  • Provisions +€339,617

    first reported in 2026, at €339,617

  • Short-term financial debts -€307,321

    down €307,321 (-5.5%), from €5.6m to €5.3m

Income statement
  • Turnover +€3.8m

    up €3.8m (+15.4%), from €24.8m to €28.6m

  • Goods and materials +€2.3m

    up €2.3m (+16.1%), from €14.4m to €16.8m

    of which Purchases: +€2.3m

  • Services and other goods +€1.5m

    up €1.5m (+34.2%), from €4.5m to €6.0m

  • Provisions +€339,617

    first reported in 2026, at €339,617

Change in the result, 2025 to 2026

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2025 €823,861
Turnover +€3.8m
Other operating income -€68,615
Goods and materials -€2.3m
Services and other goods -€1.5m
Staff costs +€59,521
Depreciation -€164,326
Write-downs +€102,949
Provisions -€339,617
Other operating charges -€33,385
Other operating items +€26,849
Financial income +€20
Financial charges -€40,148
Taxes +€45,427
Result 2026 €370,209
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2025 to 2026

The bridge is derived from the 2025 and 2026 balance sheets and the 2026 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€2.0m
Investment -€1.7m
Financing -€307,321
Cash 2025 €14,919
Net result for the year +€370,209
Depreciation +€921,926
Stocks and contracts +€141,148
Receivables within one year -€377,215
Deferred charges and accrued income +€35,726
Provisions +€339,617
Trade debts +€2.0m
Tax, wage and social debts -€276,071
Other debts -€1.1m
Investment in fixed assets (net) -€1.7m
Short-term financial debts -€307,321
Cash 2026 €19,800
brings cash intakes cash out
Every line side by side 70 lines
Line Code 2025 2026 Change %
Total assets 20/58 €11,253,384 €12,191,921 +€938,537 +8.3%
Fixed assets 21/28 €3,864,773 €4,598,088 +€733,315 +19.0%
Intangible fixed assets 21 €697,719 €664,372 -€33,347 -4.8%
Tangible fixed assets 22/27 €3,167,054 €3,933,716 +€766,662 +24.2%
Land and buildings 22 €1,712,049 €2,588,163 +€876,114 +51.2%
Plant, machinery and equipment 23 €1,280,976 €1,148,504 -€132,472 -10.3%
Furniture and vehicles 24 €174,029 €196,136 +€22,107 +12.7%
Assets under construction and advance payments 27 - €913 +€913
Current assets 29/58 €7,388,611 €7,593,833 +€205,222 +2.8%
Stocks and contracts in progress 3 €2,586,787 €2,445,639 -€141,148 -5.5%
Stocks 30/36 €2,586,787 €2,445,639 -€141,148 -5.5%
Raw materials and consumables 30/31 €11,767 €11,767 = 0.0%
Goods purchased for resale 34 €2,575,020 €2,433,872 -€141,148 -5.5%
Amounts receivable within one year 40/41 €4,596,709 €4,973,924 +€377,215 +8.2%
Trade receivables 40 €3,018,277 €3,363,178 +€344,901 +11.4%
Other amounts receivable 41 €1,578,432 €1,610,746 +€32,314 +2.0%
Cash at bank and in hand 54/58 €14,919 €19,800 +€4,881 +32.7%
Deferred charges and accrued income 490/1 €190,196 €154,470 -€35,726 -18.8%
Total equity and liabilities 10/49 €11,253,384 €12,191,921 +€938,537 +8.3%
Equity 10/15 €195,662 €565,871 +€370,209 +189%
Contributions 10/11 €122,000 €122,000 = 0.0%
Capital 10 €122,000 €122,000 = 0.0%
Issued capital 100 €122,000 €122,000 = 0.0%
Reserves 13 €45,650 €45,650 = 0.0%
Non-distributable reserves 130/1 €12,200 €12,200 = 0.0%
Legal reserve 130 €12,200 €12,200 = 0.0%
Tax-exempt reserves 132 €33,450 €33,450 = 0.0%
Profit (loss) carried forward 14 €28,012 €398,221 +€370,209 +1,322%
Provisions and deferred taxes 16 - €339,617 +€339,617
Provisions for liabilities and charges 160/5 - €339,617 +€339,617
Other liabilities and charges 164/5 - €339,617 +€339,617
Amounts payable 17/49 €11,057,722 €11,286,433 +€228,711 +2.1%
Amounts payable within one year 42/48 €11,033,782 €11,262,493 +€228,711 +2.1%
Financial debts 43 €5,576,643 €5,269,322 -€307,321 -5.5%
Other loans 439 €5,576,643 €5,269,322 -€307,321 -5.5%
Trade debts 44 €3,019,225 €4,981,008 +€2.0m +65.0%
Suppliers 440/4 €3,019,225 €4,981,008 +€2.0m +65.0%
Taxes, remuneration and social security 45 €1,288,234 €1,012,163 -€276,071 -21.4%
Taxes 450/3 €589,772 €316,427 -€273,345 -46.3%
Remuneration and social security 454/9 €698,462 €695,736 -€2,726 -0.4%
Other amounts payable 47/48 €1,149,680 - -€1.1m
Accrued charges and deferred income 492/3 €23,940 €23,940 = 0.0%
Operating income 70/76A €26,803,373 €30,578,211 +€3.8m +14.1%
Turnover 70 €24,801,656 €28,623,047 +€3.8m +15.4%
Other operating income 74 €1,990,731 €1,922,116 -€68,615 -3.4%
Non-recurring operating income 76A €10,986 €33,048 +€22,062 +201%
Operating charges 60/66A €25,481,281 €29,715,070 +€4.2m +16.6%
Goods for resale, raw materials and consumables 60 €14,443,041 €16,767,778 +€2.3m +16.1%
Purchases 600/8 €14,324,799 €16,656,794 +€2.3m +16.3%
Change in stocks: decrease (increase) 609 €118,242 €110,984 -€7,258 -6.1%
Services and other goods 61 €4,499,096 €6,038,077 +€1.5m +34.2%
Remuneration, social security and pensions 62 €5,510,378 €5,450,857 -€59,521 -1.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €757,600 €921,926 +€164,326 +21.7%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €190,135 €87,186 -€102,949 -54.1%
Provisions for liabilities and charges: additions (uses and reversals) 635/8 - €339,617 +€339,617
Other operating charges 640/8 €71,560 €104,945 +€33,385 +46.7%
Non-recurring operating charges 66A €9,471 €4,684 -€4,787 -50.5%
Operating profit (loss) 9901 €1,322,092 €863,141 -€458,951 -34.7%
Financial income 75/76B €17 €37 +€20 +118%
Recurring financial income 75 €17 €37 +€20 +118%
Other financial income 752/9 €17 €37 +€20 +118%
Financial charges 65/66B €135,196 €175,344 +€40,148 +29.7%
Recurring financial charges 65 €135,196 €175,344 +€40,148 +29.7%
Debt charges 650 €117,881 €149,220 +€31,339 +26.6%
Other financial charges 652/9 €17,315 €26,124 +€8,809 +50.9%
Profit (loss) for the period before taxes 9903 €1,186,913 €687,834 -€499,079 -42.0%
Income taxes 67/77 €363,052 €317,625 -€45,427 -12.5%
Taxes 670/3 €363,052 €317,625 -€45,427 -12.5%
Profit (loss) for the period 9904 €823,861 €370,209 -€453,652 -55.1%
Profit (loss) for the period to be appropriated 9905 €823,861 €370,209 -€453,652 -55.1%

Value

latest balance sheet 31-01-2026 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€2.2m to €3.1m

Midpoint €2.5m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity -€98,501
Capitalised earnings €4.4m to €6.2m
Indication €2.2m to €3.1m

Adjusted equity

balance sheet 31-01-2026
Equity (10/15)
€565,871
Intangible fixed assets (21)
-€664,372
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€98,501

Capitalised earnings

net result for the year (9904)
2026
€370,209
excluding non-recurring income and charges
€341,845
2025
€823,861
excluding non-recurring income and charges
€822,346
2024
€709,334
excluding non-recurring income and charges
€698,909
2023
€988,996
excluding non-recurring income and charges
€996,728
2022
€693,073
excluding non-recurring income and charges
€681,949
Average result, excluding non-recurring income and charges
€621,033
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€4.4m / €5.2m / €6.2m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 January 2025 and 31 January 2026. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.